SG/CALL/CVS HEALTH/95/0.1/20.12.24 Share Price

Warrant

DE000SU6EY05

Real-time Boerse Frankfurt Warrants 08:53:23 20/05/2024 BST
0.032 EUR +3.23% Intraday chart for SG/CALL/CVS HEALTH/95/0.1/20.12.24
Current month-38.00%
1 month-50.00%
Date Price Change
20/05/24 0.032 +3.23%
17/05/24 0.031 +3.33%
16/05/24 0.03 +25.00%
15/05/24 0.024 +9.09%
14/05/24 0.022 -18.52%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 08:53 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SU6EY0
ISINDE000SU6EY05
Date issued 29/12/2023
Strike 95 $
Maturity 20/12/2024 (215 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.01
Spread 0.01
Spread %23.81%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.68 USD
Average target price
71.37 USD
Spread / Average Target
+23.74%
Consensus